We had the great pleasure of hosting a fantastic guest PhD student, Bridget Fisher, from @ProfSharonLewin's lab @TheDohertyInst for our joint work on improving cellular shock-and-kill strategies for #HIVcure. Shock is easy to spot, but kill is the hard part. Great job Bridget☺️!

Absolutely privileged to have met @MichelSidibe, AU Envoy for @AU_AMA_, former UNAIDS Director & Mali Health Minister. Our chat spanned topics ranging from #HIVcure development to future implementation. Should a cure be discovered, do we have systems to ensure equitable access?

#InternationalWomensDay2025 “When I’m sometimes asked 'When will there be enough?’ and I say ‘When there are nine,’ people are shocked. But there'd been nine men, and nobody's ever raised a question about that.” Ruth Bader Ginsburg 1933-2020

Team had a lovely Christmas Party today. Following an Old Dock Tour and a hot drink on nearby Christmas Market, festive dinner at @TheQuarterLivpl including nerdy Christmassy Quiz 🎅! Reflecting funny stories of our first full year @LSTMnews and looking forward to those of 2025!

Great to speak at #FISHIS24 @HISConf today on our efforts to understand HIV-1 latency reversal and advance #HIVCure. And I learned a lot about development of resistance by fungi today 😀!

Team Goffinet @LSTMnews Away Day with Bowling and Turkish Late Lunch. A pleasant reminder of the importance to share, as a team, funny and enjoyable moments not only by doing science together 🤩!

On the way home from #KSRNAVirus25 Positive Strand RNA Virus Meeting at beautiful Killarney with lots of inspiration and ideas. Thanks to the organisors and @KeystoneSymp for setting up this great meeting keystonesymposia.org/confere……

Lovely Indian Summer Party in sunny Liverpool, celebrating the first anniversary of the team @lstm together with alumni, family and friends!

Thanks for the invite to give a keynote at the 2nd Symposium on HIV Immunology, Vaccine and Cure Research in Essen, Germany, and for organising this great meeting @UniklinikEssen @Schwarzer_Lab! #HIVCure

Infection is sensitive to type I IFN treatment, and reduced by Tecovirimat and Cidofovir. Keen to compare to clade I viruses and to test for a role of PBMCs in intra-host dissemination!